S-Adenosylhomocysteine (SAH) – Function and Significance
S-Adenosylhomocysteine (SAH) is a natural metabolic byproduct formed during the methylation cycle. It serves as a key biomarker for cellular methylation capacity and cardiovascular health.
Things worth knowing about "S-Adenosylhomocysteine"
S-Adenosylhomocysteine (SAH) is a natural metabolic byproduct formed during the methylation cycle. It serves as a key biomarker for cellular methylation capacity and cardiovascular health.
What is S-Adenosylhomocysteine?
S-Adenosylhomocysteine (SAH), also abbreviated as AdoHcy, is a naturally occurring biochemical compound found in every cell of the human body. It is produced as the direct metabolic byproduct of S-adenosylmethionine (SAM), the primary methyl group donor in human metabolism. SAH plays a central role in the one-carbon metabolism pathway and is closely linked to homocysteine metabolism.
Formation and Metabolism
Within the methylation cycle, SAM donates a methyl group to various substrates including DNA, RNA, proteins, and lipids. In doing so, SAM is converted into SAH. SAH is subsequently cleaved by the enzyme S-adenosylhomocysteine hydrolase (SAHH) into homocysteine and adenosine. This reaction is reversible -- under physiological conditions, the equilibrium favors SAH synthesis when homocysteine is not rapidly metabolized.
- SAM donates a methyl group and is converted to SAH.
- SAH is cleaved by SAHH into homocysteine and adenosine.
- Homocysteine is either remethylated back to methionine or further processed via the transsulfuration pathway.
Biological Significance
SAH is a potent inhibitor of numerous methyltransferases -- enzymes responsible for transferring methyl groups to other molecules. An increase in SAH levels therefore directly inhibits important methylation processes in the body, including:
- DNA methylation (epigenetic regulation)
- Protein methylation (e.g., histone modification)
- Phospholipid methylation (membrane function)
- Neurotransmitter synthesis
Since the ratio of SAM to SAH (the SAM/SAH ratio or methylation index) reflects the overall methylation status of a cell, SAH is considered an important biomarker for cellular methylation capacity.
Clinical Relevance
Elevated SAH levels in the blood have been associated with various medical conditions:
- Cardiovascular disease: SAH is considered an independent risk factor for atherosclerosis and coronary artery disease -- potentially even more informative than homocysteine alone.
- Chronic kidney disease: Since the kidneys play a major role in SAH clearance, impaired kidney function frequently leads to elevated SAH levels.
- Neurological disorders: Altered SAH levels have been observed in neurodegenerative conditions such as Alzheimer disease and Parkinson disease.
- Liver disease: The liver is the primary organ of methylation metabolism; liver conditions can significantly disrupt SAH metabolism.
- Diabetes mellitus: Studies have shown altered SAM/SAH ratios in type 2 diabetes.
Diagnosis and Measurement
SAH can be measured in blood plasma or whole blood, typically using high-performance liquid chromatography (HPLC) or liquid chromatography-tandem mass spectrometry (LC-MS/MS). Measuring SAH together with SAM allows calculation of the SAM/SAH ratio, which serves as an indicator of methylation capacity. Reference ranges vary by laboratory and method; elevated values may indicate impaired methylation function.
Factors Influencing SAH Levels
Various factors can affect SAH levels in the body:
- Diet: Deficiencies in folate, vitamin B12, vitamin B6, and riboflavin impair homocysteine and SAH metabolism.
- Kidney function: Reduced kidney function leads to elevated SAH levels.
- Medications: Certain drugs such as methotrexate or antiviral agents can interfere with SAH metabolism.
- Genetic factors: Polymorphisms in genes such as MTHFR or SAHH can alter SAH regulation.
- Oxidative stress: Chronic oxidative stress can disrupt methylation metabolism.
Therapeutic Approaches
Actively lowering elevated SAH levels is not yet an established standard therapeutic target; however, the following measures can support the methylation cycle:
- Adequate intake of folate (vitamin B9), vitamin B12, and vitamin B6, which are essential for homocysteine remethylation.
- Betaine (trimethylglycine) as an alternative methyl group donor.
- Treatment of underlying conditions (e.g., kidney insufficiency, liver disease).
- Dietary adjustments including foods rich in methyl-group nutrients (e.g., eggs, liver, legumes, leafy green vegetables).
References
- Mato, J.M. et al. - S-Adenosylmethionine metabolism and liver disease. In: Annals of Hepatology, 2013.
- Ueland, P.M. - Homocysteine species as components of plasma redox thiol status. In: Clinical Chemistry, 1995.
- Fowler, B. - Homocysteine: overview of biochemistry, molecular biology, and role in disease processes. In: Seminars in Vascular Medicine, 2005.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryCalorie deficit
Macronutrients
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: S-Adenosylhomocysteine-en